Company: Diadia Health
Founder: Elena Ikonomovska
Website: https://www.diadiahealth.com/
About Diadia Health
Healthcare AI has a trust problem. Clinicians are flooded with tools that surface statistically plausible answers, then routinely discover those answers are wrong. A Harvard study found 91.8% of clinicians had encountered AI suggestions that looked credible but were clinically incorrect. In high-stakes medicine, plausible is not good enough.
Diadia Health, founded in 2021 by Elena Ikonomovska, PhD, is the first AI causal reasoning platform built for precision medicine in complex chronic disease – and the first to approach clinical AI not as a prediction engine, but as a reasoning engine. Where pattern-matching AI asks what this case looks like, Diadia asks why it is happening, modelling the biological mechanisms behind each patient instead of matching to population averages.
The challenge was technical and cultural. Elena, an AI scientist by training who prototyped infrastructure that became foundational to Google BigQuery and served as the first data scientist at Reddit, had spent over two decades building large-scale machine learning systems. She watched the rest of the industry race toward bigger models and faster predictions. Diadia took the opposite path: build an auditable reasoning chain that a clinician can verify before acting. That meant solving causal inference, transparency, and clinical-grade evidence retrieval at the same time, against an industry default of black-box outputs.
Today the platform synthesises nearly 30 million genetic variants and 200+ multi-omic biomarkers per patient, grounded in 310,000+ peer-reviewed papers, to generate evidence-backed clinical reports. The result is an architecture in which hallucinated outputs are not just rare; they are structurally prevented. Every reasoning step is traceable. Every recommendation is one that a clinician can challenge and validate.
Diadia exited beta in March 2026 and is now deployed nationally with leading clinical sites in functional, integrative, and longevity medicine. The platform is delivering what is rare for clinical AI: specialist-level diagnostic depth without the referral lag, faster resolution of complex chronic cases, and a level of clinician trust that comes only from being able to inspect and validate every step of the reasoning. Clinic partnerships are scaling rapidly post-launch.
The impact on the AI industry is twofold. First, Diadia is proving that ethical, transparent AI is not a constraint on performance; it is the unlock for adoption in regulated fields where pattern-matching has stalled. Second, Diadia is reaching the patients most failed by population-based medicine: the 100M+ women navigating perimenopause, hormonal dysfunction, complex metabolic disease, and autoimmune conditions who wait years longer than men to receive a correct diagnosis. The reasoning engine that closes that gap is universal, and it is now being applied to any patient whose biology defies the standard clinical script.
Elena was named #2 on TechRound 50 Women in Tech 2026. Diadia is the clinical intelligence layer that finally makes precision medicine operational, for the patients who have been waiting the longest.
Want to find out what TechRound can do for your business?
